Addiction

Unite Us Receives Grant to Combat Ohio’s Opioid Crisis and Expand Recovery Services in Montgomery CountyUnite Us Receives Grant to Combat Ohio’s Opioid Crisis and Expand Recovery Services in Montgomery County

Unite Us Receives Grant to Combat Ohio’s Opioid Crisis and Expand Recovery Services in Montgomery County

Funding from OneOhio Recovery Foundation will drive technology-enabled recovery services and increase access to critical support for Ohioans impacted by…

2 months ago
Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plcAwakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc

Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc

Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"…

2 months ago
Aura Unites with Boston Children’s Hospital to Address the Role of Technology in the Crisis of Wellbeing Among American ChildrenAura Unites with Boston Children’s Hospital to Address the Role of Technology in the Crisis of Wellbeing Among American Children

Aura Unites with Boston Children’s Hospital to Address the Role of Technology in the Crisis of Wellbeing Among American Children

This collaboration aims to give parents and families the tools and resources they need to live safe, balanced online lives.…

2 months ago
Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for…

2 months ago
Q2i, King’s College London, and UK Government Join Forces to Revolutionize Prisoner Reintegration with AIQ2i, King’s College London, and UK Government Join Forces to Revolutionize Prisoner Reintegration with AI

Q2i, King’s College London, and UK Government Join Forces to Revolutionize Prisoner Reintegration with AI

BOSTON, Feb. 24, 2025 /PRNewswire/ -- Q2i, a leader in digital innovation, has announced that its contingency management division (CMI)…

2 months ago
SOBRsafe and Orbiit Announce Partnership to Enhance Alcohol Recovery Through AI and Wearable TechnologySOBRsafe and Orbiit Announce Partnership to Enhance Alcohol Recovery Through AI and Wearable Technology

SOBRsafe and Orbiit Announce Partnership to Enhance Alcohol Recovery Through AI and Wearable Technology

DENVER, Feb. 20, 2025 /PRNewswire/ -- SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), the leader in next-generation alcohol detection technology, and Orbiit, an…

2 months ago
Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug DependenciesAdial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

 New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders…

2 months ago
NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcareNEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcare

NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcare

Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM. AUSTIN, Texas,…

2 months ago
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from MerckNeuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 nicotinic…

3 months ago
St. Joe’s Emergency Department Transformation Now CompleteSt. Joe’s Emergency Department Transformation Now Complete

St. Joe’s Emergency Department Transformation Now Complete

West end Toronto emergency department is 40% larger, fully donor-fundedTORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- St. Joseph’s Health Centre…

3 months ago